软组织同种异体移植市场规模预计将从 2024 年的 40.8849 亿美元增至 2031 年的 67.4828 亿美元。预计 2024-2031 年期间市场复合年增长率将达到 7.4%。在预测期内,定制移植的发展可能会带来新的市场趋势。
软组织同种异体移植市场分析
运动相关的伤害,尤其是运动员和身体活跃人士的伤害,通常涉及软组织损伤。由于身体活动,世界各地报告了几起伤害事件。例如,根据国家安全委员会的数据,2023 年,美国有 370 万人因受伤在急诊室接受治疗。从 2022 年到 2023 年,运动伤害和运动器材伤害增加了 8%;受伤人数从 2022 年的 445,642 人增加到 2023 年的 482,886 人。15-24 岁年龄组的受伤率最高;男性受伤人数多于女性(男性 276,377 人 vs. 女性 206,381 人),90% 的受伤者在急诊室接受治疗。根据国家医疗服务体系 (NHS) 的数据,英国每年约有 200 万人因运动伤害在“急诊”部门住院。根据豪登欧洲男子足球伤病指数,2023-2024 赛季欧洲五大联赛共报告 4,123 人受伤,比上赛季(2022-2023 年)增加 4%。这些伤病共计 7.3202 亿欧元(7.987 亿美元),反映出整体伤病相关费用增加 5%。
运动和体育活动期间造成的伤害增加了对软组织异体移植的需求,用于修复或更换受损组织。当损伤过于严重,身体无法通过固有修复机制或传统治疗方法治愈时,软组织异体移植可用于修复或重建受损组织。自 1980 年代以来,异体移植已在运动医学中常规使用。软组织异体移植被视为膝关节手术中重建撕裂半月板、韧带缺陷和骨软骨缺损的重要替代组织。这些程序允许在重建手术中使用更标准化的移植物,特别是在移植物直径、完整性、形状和可重复性方面。此外,由于手术时间更短、手术效率更高、供体部位发病率更低,这种技术已成为外科医生眼中自体移植的一种有吸引力的替代方案。因此,软组织异体移植市场的增长可以归因于运动损伤和创伤发生率的上升。
软组织同种异体移植市场概况
由于人口老龄化加剧,运动损伤和创伤发生率上升,软组织异体移植市场正在迅速扩张。市场上的知名企业正致力于创新和合作,以提高产品可用性。然而,手术费用高昂阻碍了软组织异体移植市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
软组织同种异体移植市场:

- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
软组织同种异体移植市场驱动因素和机遇
运动损伤和创伤发生率上升推动市场增长
运动相关的伤害,尤其是运动员和身体活跃人士的伤害,通常涉及软组织损伤。由于身体活动,世界各地报告了几起伤害事件。例如,根据国家安全委员会的数据,2023 年,美国有 370 万人因受伤在急诊室接受治疗。从 2022 年到 2023 年,运动伤害和运动器材伤害增加了 8%;受伤人数从 2022 年的 445,642 人增加到 2023 年的 482,886 人。15-24 岁年龄组的受伤率最高;男性受伤人数多于女性(男性 276,377 人 vs. 女性 206,381 人),90% 的受伤者在急诊室接受治疗。根据国家医疗服务体系 (NHS) 的数据,英国每年约有 200 万人因运动伤害在“急诊”部门住院。根据豪登欧洲男子足球伤病指数,2023-2024 赛季欧洲五大联赛共报告 4,123 人受伤,比上赛季(2022-2023 年)增加 4%。这些伤病共计 7.3202 亿欧元(7.987 亿美元),反映出整体伤病相关费用增加 5%。
运动和体育活动期间造成的伤害增加了对软组织异体移植的需求,用于修复或更换受损组织。当损伤范围过大,身体无法通过固有修复机制或传统治疗方法治愈时,软组织异体移植可用于修复或重建受损组织。自 1980 年代以来,异体移植已在运动医学中常规使用。软组织异体移植被视为膝关节手术中重建撕裂半月板、韧带缺陷和骨软骨缺损的重要替代组织。这些程序允许在重建手术中使用更标准化的移植物,特别是在移植物直径、完整性、形状和可重复性方面。此外,由于手术时间更短、手术效率更高、供体部位发病率更低,这种技术已成为外科医生眼中自体移植的一种有吸引力的替代方案。因此,软组织异体移植市场的增长可以归因于运动损伤和创伤发生率的上升。
新产品发布创造市场利润机会
一些公司正致力于通过广泛的研究开发创新产品。与现有产品相比,这些产品可能会提供更好的治疗效果。例如,AlloSource 是美国最大的同种异体移植提供商之一,提供创新的细胞和组织产品,帮助医疗保健提供者治愈患者。2023 年 5 月,该公司宣布推出 AlloMend Duo 无细胞真皮基质 (ADM),这是一种用于软组织重建的天然解决方案。2024 年 6 月,开发用于周围神经损伤的创新手术解决方案的全球领导者 Axogen, Inc. 宣布推出其新产品 Avive+ 软组织基质。该产品旨在用作软组织屏障;它是一种可吸收的多层羊膜同种异体移植,旨在在周围神经愈合的关键阶段提供临时保护和组织分离。 2022 年 2 月,羊膜组织异体移植开发和分销领域的全球领导者 Amnio Technology 宣布推出其 PalinGen 膜系列中的两款新产品:PalinGen 双层膜和双层 PalinGen X 膜。与 PalinGen 系列中的所有产品一样,这些新的异体移植材料经过了最低限度的修改,旨在用于同源用途。近年来推出的新型软组织异体移植产品旨在满足不断变化的患者需求、缩短恢复时间、减少并发症并解决各种临床适应症。推出更多此类产品预计将在未来几年为软组织异体移植市场创造巨大的增长机会。
软组织同种异体移植市场报告细分分析
有助于得出软组织同种异体移植市场分析的关键部分是类型、应用和最终用户。
- 根据类型,软组织异体移植市场细分为软骨异体移植、肌腱异体移植、牙异体移植、半月板异体移植、胎盘组织等。软骨异体移植部分在 2024 年占据了最大的市场份额。
- 从应用方面来看,软组织同种异体移植市场分为骨科、牙科、伤口护理等。骨科领域在 2024 年占据了市场主导地位。
- 就最终用户而言,软组织同种异体移植市场分为医院、专科诊所和其他。医院部门在 2024 年占据了市场主导地位。
软组织同种异体移植市场份额按地区分析
软组织异体移植市场报告的地理范围主要集中在五个地区:北美、亚太地区、欧洲、南美和中美以及中东和非洲。就收入而言,北美在 2024 年占据了市场主导地位。预计在预测期内,它将继续在全球市场占据主导地位。美国是世界上最大的软组织异体移植市场。它占软组织异体移植市场的很大一部分,每年进行的手术数量相当可观。根据 2024 年发表的一项题为“受蟒蛇牙齿启发的新设备使肩袖强度加倍”的研究,美国每年进行的肩袖手术超过 600,000 例。根据美国运动医学骨科协会的数据,该国每年报告的 ACL 断裂病例接近 100,000 至 250,000 例。多种组织损伤已受到高度重视,提高了运动员对软组织损伤及其治疗的认识。 2023 年 5 月,AlloSource 宣布推出 AlloMend Duo 无细胞真皮基质 (ADM),这是一种专为软组织重建而设计的天然解决方案。它是美国最大的非营利性异体移植提供商之一,以开发创新的细胞和组织产品来帮助外科医生治愈患者而闻名。ADM 的开发是为了帮助外科医生修复和重建软组织缺损,提供长期的结构支持。这种深层网状真皮异体移植与周围组织整合,充当支架,促进细胞重新繁殖和天然宿主组织再生。其灵活易弯的特性使其成为各种医疗程序的理想选择,这些程序要求人体再生组织基质具有强度和生物相容性,从而可以精确放置和最佳处理。
软组织同种异体移植市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响软组织异体移植市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的软组织异体移植市场细分和地理分布。

- 获取软组织同种异体移植市场的区域特定数据
软组织同种异体移植市场报告范围
报告属性 | 细节 |
---|---|
2024 年的市场规模 | 40.8849亿美元 |
2031 年市场规模 | 67.4828亿美元 |
全球复合年增长率(2024 - 2031) | 7.4% |
史料 | 2021-2023 |
预测期 | 2024-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
软组织同种异体移植市场参与者密度:了解其对业务动态的影响
软组织同种异体移植市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在软组织同种异体移植市场运营的主要公司有:
- 捷迈邦美控股公司
- 康美德公司
- 史赛克公司
- 史密斯和侄子公司
- Integra 生命科学控股公司
- Arthrex公司
免责声明:上面列出的公司没有按照任何特定顺序排列。

- 了解软组织同种异体移植市场顶级关键参与者概况
软组织同种异体移植市场新闻和最新发展
软组织同种异体移植市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是软组织同种异体移植市场见证的一些关键发展:
- Dentsply Sirona 更新了其 Symbios Allograft 产品线,强调增强的无菌性和多功能性。增强的 Symbios Allograft 系列提供矿化和脱矿再生解决方案,可满足各种牙科手术和植入需求。这些产品旨在促进骨形成、增加体积并确保稳定性,以实现可预测的长期结果。更新后的产品组合包括新的颗粒同种异体移植物、腻子产品和称为 Symbios PerioDerm 的无细胞真皮基质。(来源:Dentsply Sirona,2024 年 7 月)
- Axogen, Inc. 推出了其最新产品 Avive+ 软组织基质。这种可吸收的多层羊膜同种异体移植物可充当软组织屏障,在周围神经损伤的关键愈合阶段提供临时保护和隔离。Avive+ 符合美国 FDA 第 1271 部分法规下对人体细胞和组织产品的要求,并符合州法规作为 361 人体组织产品的要求。(来源:Axogen, Inc.,新闻稿,2024 年 6 月)
软组织同种异体移植市场报告覆盖范围和交付成果
“软组织同种异体移植市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:
- 范围内涵盖的所有主要细分市场的全球、区域和国家层面的软组织同种异体移植市场规模和预测
- 软组织同种异体移植市场趋势,以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST 和 SWOT 分析
- 软组织同种异体移植市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及软组织同种异体移植市场的最新发展
- 详细的公司简介
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
The soft tissue allografts market value is expected to reach US$ 6,748.28 million by 2031.
The market is expected to register a CAGR of 7.4% during 2024–2031.
The development of customized grafts is likely to emerge as a new growth trend in the market in the coming years.
Zimmer Biomet Holdings Inc, Conmed Corp, Stryker Corp, Smith & Nephew Plc, Integra LifeSciences Holdings Corp, Arthrex Inc, AbbVie Inc, Organogenesis Inc., Dentsply Sirona Inc, and Axogen Corporation are among the key players operating in the market.
North America dominated the market in 2024.
An increasing aging population, and the rising incidence of sports injuries and trauma are among the most significant factors fueling the market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Soft Tissue Allografts Market
- Stryker Corp
- Smith & Nephew Plc
- Integra LifeSciences Holdings Corp
- Arthrex Inc
- AbbVie Inc
- Organogenesis Inc.
- Dentsply Sirona Inc
- Axogen Corporation
- Zimmer Biomet Holdings Inc
- Conmed Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.